These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12083943)

  • 1. Clinical importance of beta-adrenoceptor polymorphisms in cardiovascular disease.
    McNamara DM; MacGowan GA; London B
    Am J Pharmacogenomics; 2002; 2(2):73-8. PubMed ID: 12083943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor polymorphism in human cardiovascular disease.
    Leineweber K
    Ann Med; 2004; 36 Suppl 1():64-9. PubMed ID: 15176426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-adrenoceptor.
    Johnson M
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S146-53. PubMed ID: 9817738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms determine beta-adrenoceptor conformation: implications for cardiovascular disease and therapy.
    Ahles A; Engelhardt S
    Trends Pharmacol Sci; 2009 Apr; 30(4):188-93. PubMed ID: 19272658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
    Leineweber K; Heusch G
    Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Adrenergic receptor gene polymorphism is a genetic risk factor for cardiovascular disease: a cohort study with hypertensive patients.
    Iwamoto Y; Ohishi M; Yuan M; Tatara Y; Kato N; Takeya Y; Onishi M; Maekawa Y; Kamide K; Rakugi H
    Hypertens Res; 2011 May; 34(5):573-7. PubMed ID: 21289629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study.
    Timmermann B; Mo R; Luft FC; Gerdts E; Busjahn A; Omvik P; Li GH; Schuster H; Wienker TF; Hoehe MR; Lund-Johansen P
    Kidney Int; 1998 Jun; 53(6):1455-60. PubMed ID: 9607174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
    Brodde OE
    Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics.
    Johnson JA; Terra SG
    Pharm Res; 2002 Dec; 19(12):1779-87. PubMed ID: 12523655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.
    Baker JG; Proudman RG; Hill SJ
    PLoS One; 2013; 8(11):e77582. PubMed ID: 24250787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor polymorphisms.
    Leineweber K; Büscher R; Bruck H; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):1-22. PubMed ID: 14647973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure.
    Wolk R; Snyder EM; Somers VK; Turner ST; Olson LJ; Johnson BD
    J Am Soc Echocardiogr; 2007 Mar; 20(3):290-7. PubMed ID: 17336757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional significance of genetic variation within the beta-adrenoceptor.
    Sandilands AJ; O'Shaughnessy KM
    Br J Clin Pharmacol; 2005 Sep; 60(3):235-43. PubMed ID: 16120061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.
    Brodde OE
    Pharmacol Ther; 2008 Jan; 117(1):1-29. PubMed ID: 17916379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
    Leineweber K; Brodde OE
    Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
    Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
    Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic receptor polymorphisms and drug responses in asthma.
    Taylor DR; Kennedy MA
    Pharmacogenomics; 2002 Mar; 3(2):173-84. PubMed ID: 11972440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha- and beta-adrenoceptors in hypertension: molecular biology and pharmacological studies.
    Michel MC; Philipp T; Brodde OE
    Pharmacol Toxicol; 1992 Jun; 70(6 Pt 2):S1-10. PubMed ID: 1354864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.